JUST IN
DLF Q3 profit jumps 37% on account of reduced costs and stable demand
Dr Reddy's Lab Q3 net up 77% at Rs 1,247 cr, revenue from operations jump
Cipla Q3 net up 10% to Rs 801 cr, posts highest ever quarterly sales in US
Indian Bank Q3 net profit doubles to Rs 1,396 cr as bad loans decline
Tata Motors Q3 result: Consolidated revenue up 22.5% to Rs 88,488 crore
TeamLease posts Q3 profit drop as revenue growth slows, costs rise
Bajaj Auto Q3 net profit up 3% at Rs 1,473 cr on back of sales growth
Cipla Q3 net profit rises 7% to Rs 808 cr on account of robust sales
United Spirits Q3 net declines 27% to Rs 214 cr, income dips to Rs 6,631 cr
Strides Pharma reports Q3 net loss of Rs 82 cr, revenue rises to Rs 865 cr
You are here: Home » Companies » Results
India's retail health insurance could be a $25 bn market in 5 yrs: Report
icon-arrow-left
Business Standard

Torrent Pharma Q3 net profit up 14% to Rs 283 cr; interim dividend declared

Net sales increased to Rs 2,459 crore in the quarter under review as against Rs 2,092 crore in the year-ago period, the company said in a regulatory filing

Topics
Torrent Pharmaceuticals | Q3 results | Interim Dividend

Press Trust of India  |  New Delhi 

Torrent Pharmaceuticals
The company's board, which met on Wednesday, declared an interim dividend of Rs 14 (280 per cent) per share of Rs 5 each.

Torrent Pharma on Wednesday said its consolidated net profit increased by 14 per cent to Rs 283 crore in the third quarter ended December 31, 2022.

The drug firm had reported a net profit of Rs 249 crore in the October-December period of previous fiscal.

Net sales increased to Rs 2,459 crore in the quarter under review as against Rs 2,092 crore in the year-ago period, the company said in a regulatory filing.

The company's board, which met on Wednesday, declared an interim dividend of Rs 14 (280 per cent) per share of Rs 5 each.

On Wednesday, shares of the company ended 1.86 per cent down at Rs 1,557.50 apiece on the BSE.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

Read our full coverage on Torrent Pharmaceuticals

First Published: Wed, January 25 2023. 18:26 IST

`
RECOMMENDED FOR YOU
.